T11	Disease 1008 1012	OSCC
T16	Disease 1331 1337	cancer
T19	Disease 1458 1464	cancer
T2	Disease 435 442	cancers
#6	AnnotatorNotes T2	DOID:162
T21	Gene-Protein 1484 1492	Vimentin
T24	Disease 1611 1618	cancers
T4	Disease 647 654	cancers
T6	Disease 734 758	hepatocellular carcinoma
#13	AnnotatorNotes T6	DOID:684
T7	Disease 770 804	esophageal squamous cell carcinoma
#14	AnnotatorNotes T7	DOID:7051
T9	Disease 861 872	OSCC cancer
#15	AnnotatorNotes T9	DOID:0050866
T3	Gene-Protein 59 64	Smad2
#2	AnnotatorNotes T3	HGNC:6768
T8	Gene-Protein 290 295	Smad2
T10	Gene-Protein 195 200	Smad2
T12	Gene-Protein 205 210	Smad4
#4	AnnotatorNotes T12	HGNC:6770
T13	RNA-Noncoding 93 103	miR-18a-5p
#8	AnnotatorNotes T13	HGNC:31548
T14	RNA-Noncoding 145 155	miR-18a-5p
T15	Gene-Protein 255 260	Smad7
#16	AnnotatorNotes T15	HGNC:6773
T18	Gene-Protein 300 305	Smad4
T22	Gene-Protein 450 455	Smad7
T1	Gene-Protein 349 355	TGF-β1
#1	AnnotatorNotes T1	HGNC:11766
T23	GeneFamily 356 360	Smad
#17	AnnotatorNotes T23	family:750
T25	Gene-Protein 569 575	TGF-β1
T27	GeneFamily 933 937	Smad
T28	Gene-Protein 926 932	TGF-β1
T29	RNA-Noncoding 1054 1064	miR-18a-5p
T30	RNA-Noncoding 1172 1182	miR-18a-5p
T31	Drug-Class 1172 1192	miR-18a-5p inhibitor
T32	RNA-Noncoding 838 848	miR-18a-5p
T33	Gene-Protein 1143 1153	E-cadherin
#18	AnnotatorNotes T33	HGNC:1748
T34	Gene-Protein 1120 1128	vimentin
#19	AnnotatorNotes T34	 HGNC:12692
T35	RNA-Noncoding 1894 1904	miR-18a-5p
T36	Gene-Protein 1667 1677	E-cadherin
T37	Gene-Protein 1744 1750	TGF-β1
T38	GeneFamily 1751 1755	Smad
T20	GeneFamily 1098 1108	collagen I
#7	AnnotatorNotes T20	not found
T26	GeneFamily 1253 1263	collagen I
T39	Gene-Protein 1110 1115	α-SMA
#10	AnnotatorNotes T39	HGNC:11117
T40	Gene-Protein 1379 1384	α-SMA
#20	AnnotatorNotes T21	HGNC:12692
T41	Biomarker 1875 1904	high expression of miR-18a-5p
T42	Collection 647 804	cancers, such as breast ( 16 ), prostate ( 17 ), and gastric cancer ( 18 ), as well as hepatocellular carcinoma ( 19 ) and esophageal squamous cell carcinoma
T43	Disease 664 714	breast ( 16 ), prostate ( 17 ), and gastric cancer
T5	Biomarker 1484 1602	Vimentin is now being perceived as a canonical prognostic marker and has been revealed to have a high expression level
R1	Association Arg1:T5 Arg2:T24	
T44	Biomarker 1379 1384	α-SMA
R2	Association Arg1:T44 Arg2:T19	
T17	Biomarker 1253 1263	collagen I
R3	Association Arg1:T17 Arg2:T16	
T45	GeneFamily 576 580	Smad
T46	Biomarker 569 598	TGF-β1/Smad signaling pathway
T47	Biomarker 838 848	miR-18a-5p
R4	Association Arg1:T47 Arg2:T9	
#3	AnnotatorNotes T43	DOID:1612,DOID:10283,DOID:10534
#5	AnnotatorNotes T44	C541116
#9	AnnotatorNotes T17	D024042
#11	AnnotatorNotes T47	C524941
R6	Association Arg1:T46 Arg2:T42	
#12	AnnotatorNotes T11	DOID:0050866
#21	AnnotatorNotes T16	DOID:162
R5	Prognostic-Poor Arg1:T41 Arg2:T24	
